PTC Therapeutics Provides a Corporate Update and Reports Third Quarter Financial Results 

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. META
10. TLT

Go back to PTC Therapeutics Provides a Corporate Update and Reports Third Quarter Financial Results 

PTC Therapeutics (PTCT) Misses Q3 EPS by 22c, Revenue Beats

October 27, 2022 4:22 PM EDT

PTC Therapeutics (NASDAQ: PTCT) reported Q3 EPS of ($1.53), $0.22 worse than the analyst estimate of ($1.31). Revenue for the quarter came in at $217.1 million versus the consensus estimate of $178.9 million.

For earnings history and earnings-related data on PTC Therapeutics (PTCT) click here.

... More